REGENERX BIOPHARMACEUTICALS INC Annual Nonoperating Income (Expense) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2022.
  • Regenerx Biopharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$80.3K, a 0.08% decline year-over-year.
  • Regenerx Biopharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$326K, a 20.9% decline year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was -$325K, a 20.9% decline from 2021.
  • Regenerx Biopharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$269K, a 17.7% decline from 2020.
  • Regenerx Biopharmaceuticals Inc annual Nonoperating Income (Expense) for 2020 was -$229K, a 60.7% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$325K -$56.2K -20.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-11
2021 -$269K -$40.4K -17.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-11
2020 -$229K -$86.5K -60.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$142K +$528K +78.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$670K -$2.5M -137% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $1.83M -$73.4K -3.86% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $1.9M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.